Preeclampsia in the Context of COVID-19: Mechanisms, Pathophysiology, and Clinical Outcomes
- PMID: 39132825
- PMCID: PMC11384281
- DOI: 10.1111/aji.13915
Preeclampsia in the Context of COVID-19: Mechanisms, Pathophysiology, and Clinical Outcomes
Abstract
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to the global COVID-19 pandemic, significantly impacting the health of pregnant women. Obstetric populations, already vulnerable, face increased morbidity and mortality related to COVID-19, aggravated by preexisting comorbidities. Recent studies have shed light on the potential correlation between COVID-19 and preeclampsia (PE), a leading cause of maternal and perinatal morbidity worldwide, emphasizing the significance of exploring the relationship between these two conditions. Here, we review the pathophysiological similarities that PE shares with COVID-19, with a particular focus on severe COVID-19 cases and in PE-like syndrome cases related with SARS-CoV-2 infection. We highlight cellular and molecular mechanistic inter-connectivity between these two conditions, for example, regulation of renin-angiotensin system, tight junction and barrier integrity, and the complement system. Finally, we discuss how COVID-19 pandemic dynamics, including the emergence of variants and vaccination efforts, has shaped the clinical scenario and influenced the severity and management of both COVID-19 and PE. Continued research on the mechanisms of SARS-CoV-2 infection during pregnancy and the potential risk of developing PE from previous infections is warranted to delineate the complexities of COVID-19 and PE interactions and to improve clinical management of both conditions.
Keywords: COVID‐19; SARS‐CoV‐2; complement system proteins; maternal morbidity; preeclampsia; renin‐angiotensin system; tight junctions.
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
Conflict of Interest Statement
GMN, BRJ and MLC declare no conflict of interest. IUM serves on the scientific advisory board of Seed Health.
Figures
References
-
- Donati S, Corsi E, Maraschini A, Salvatore MA, the ItOSS-COVID-19 Working Group. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study. BJOG An Int J Obstet \& Gynaecol. 2022;129(2):221–231. doi: 10.1111/1471-0528.16980 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- 88887.891986/2023-00/CAPES Institutional Internationalization Program (CAPES/PrInt)
- 408407/2021-2/Brazilian National Council for Scientific and Technological Development (CNPq)
- T32 GM136554/GM/NIGMS NIH HHS/United States
- 308378/2022-9/Brazilian National Council for Scientific and Technological Development (CNPq)
- 88887.712761/2022-00/Brazilian Coordination of Superior Level Staff Improvement (CAPES)
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
